Abstract 478: Targeted combination nano-drug delivery system to enhance anti-cancer efficacy and reduce side effects
Niloufar Rashidi(Iran University of Medical Sciences), Kulmira Nurgali(Victoria University), Vasso Apostolopoulos(Australian Institute for Musculoskeletal Science), Majid Davidson(Victoria University), Mark R. Kelley(University of Indianapolis)
Cited by 2
Related Papers
The Intracellular Localization of APE1/Ref-1: More than a Passive Phenomenon?
|Antioxidants and Redox Signaling|2005|379
Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations
|Cancers|2021|342
Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments
|Frontiers in Pharmacology|2016|239
Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic
|npj Precision Oncology|2017|155
The Role of Tryptophan Metabolites in Neuropsychiatric Disorders
|International Journal of Molecular Sciences|2022|152